elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26784569-4D9BD11C-8A93-44FD-9D38-62EC0AEB716D
Q26784569-4D9BD11C-8A93-44FD-9D38-62EC0AEB716D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784569-4D9BD11C-8A93-44FD-9D38-62EC0AEB716D
Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics
P2860
Q26784569-4D9BD11C-8A93-44FD-9D38-62EC0AEB716D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784569-4D9BD11C-8A93-44FD-9D38-62EC0AEB716D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55e6b6617e4aeecf9e2920f1610e3c799bd7d4fd
P2860
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.